Antibody-based immunotherapy in high-risk neuroblastoma. - Wikidata - wikimedia - TriplyDB

Antibody-based immunotherapy in high-risk neuroblastoma.

Antibody-based immunotherapy in high-risk neuroblastoma.

http://www.wikidata.org/entity/Q34725758

about

Cellular immunotherapy for pediatric solid tumors New aspects of neuroblastoma treatment: ASPHO 2011 symposium review The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma.Anti-GD2 Strategy in the Treatment of Neuroblastoma Morus alba Accumulates Reactive Oxygen Species to Initiate Apoptosis via FOXO-Caspase 3-Dependent Pathway in Neuroblastoma Cells.Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome based on observations in high-risk neuroblastoma.Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 study.Cellular immunotherapy for neuroblastoma: a review of current vaccine and adoptive T cell therapeutics.Toxicological and efficacy assessment of post-transition metal (Indium) phthalocyanine for photodynamic therapy in neuroblastoma Modulation of CD59 expression by restrictive silencer factor-derived peptides in cancer immunotherapy for neuroblastoma.

P2860

Q27014912-31997BB5-35CC-455F-B9AA-60E58E371497 Q33922797-EF1473D2-F61C-4F96-8176-BDB5FEE01EE8 Q34186886-45A5E176-9F4D-4A05-B8CF-5D5D24472582 Q34243887-B8D787B3-E325-4958-A9BE-09717AB6F6C3 Q35865049-BF5E4A38-C98A-4ACF-ABA7-278E43D8BF9A Q35963440-CC201505-13F3-4BAA-A445-76525A3F02C7 Q37364364-9C0DAF73-E458-471E-9C78-BF16A2DD78D2 Q37387518-CAFB1661-7983-42DA-A420-EA1AB769952C Q37688430-F1740CD6-D882-4C30-9B8B-56F66B28CD37 Q39960663-A805433D-DF60-4337-AAC4-8BC38879245D

P2860

Antibody-based immunotherapy in high-risk neuroblastoma.

http://www.wikidata.org/entity/Q34725758

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

name

Antibody-based immunotherapy in high-risk neuroblastoma.

@ast

Antibody-based immunotherapy in high-risk neuroblastoma.

@en

Antibody-based immunotherapy in high-risk neuroblastoma.

@nl

type

label

Antibody-based immunotherapy in high-risk neuroblastoma.

@ast

Antibody-based immunotherapy in high-risk neuroblastoma.

@en

Antibody-based immunotherapy in high-risk neuroblastoma.

@nl

prefLabel

Antibody-based immunotherapy in high-risk neuroblastoma.

@ast

Antibody-based immunotherapy in high-risk neuroblastoma.

@en

Antibody-based immunotherapy in high-risk neuroblastoma.

@nl

P1433

Q34725758-9D05D6B6-7884-4168-98ED-C273C5ED9B61

P1476

Q34725758-1905D275-4217-43BF-8124-29D57A0280D7

P2093

Q34725758-4345BB1E-4E42-4E75-A946-E90864135B6E

Q34725758-4EE2470F-C5CB-41FD-A9BC-AFD68A0718B2

Q34725758-69D8CD1D-846F-430D-99D5-A014A7511998

P2860

Q34725758-22066DA1-75A8-4B46-ADFC-47649ECC6911

Q34725758-26B4BCAE-D09F-4162-AAAF-B8114E20439A

Q34725758-2FA866C2-8DF3-43BB-809B-0FF7F7D2DCAB

Q34725758-3189E698-B719-4DEB-ABCE-2FE03AAB9F80

Q34725758-3244875E-4BA6-4E05-91C2-2DF57EE8375F

Q34725758-33F5A81E-2A46-44F4-B8E4-09BA39525A8E

Q34725758-390695B9-BCC2-4AD4-9212-6F520EFF6CC2

Q34725758-3932F3AD-09AA-4358-9A42-DE179763FE38

Q34725758-47F27E4F-9543-404D-A382-C6542023F49C

Q34725758-486CB666-AE21-424B-96A1-D74FB0FBA8FC

P304

Q34725758-0C201DF8-4141-43B2-AD11-35879E06966C

P31

Q34725758-3A02A06D-89AA-4EB6-A80C-FDD1B6F8EE1D

P356

Q34725758-AF0CCF2F-772E-4107-BF49-84B8B97CB784

P433

Q34725758-780F48B0-A5F8-4AB0-820A-681B837A4DBF

P478

Q34725758-601BBC9D-6591-4A86-B719-9E290272EE91

P577

Q34725758-0234192A-3A7C-4A39-8B07-3CD7B1A42958

P5875

Q34725758-9FAEB41C-8F6D-4FC3-80E5-3E20054993A3

P698

Q34725758-470117E2-39BB-4A1E-AA86-8EEFE2A8D141

P921

Q34725758-230A61A8-A14E-47E6-8E43-20CD42365003

Q34725758-FE2C7377-7151-4723-852D-702B0965DDF5

P356

S1462399407000518

P1433

Expert Reviews in Molecular Medicine

P1476

Antibody-based immunotherapy in high-risk neuroblastoma.

@en

P2093

Erik Johnson

http://www.w3.org/2001/XMLSchema#string

Paul M Sondel

http://www.w3.org/2001/XMLSchema#string

Shannon M Dean

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models

Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group

Mechanisms of ganglioside inhibition of APC function.

Immune evasion of tumor cells using membrane-bound complement regulatory proteins.

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

Monoclonal antibody-based therapy for neuroblastoma.

Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma.

Antibody-directed, effector cell-mediated tumor destruction.

Monoclonal antibody-based therapy of neuroblastoma.

P304

1-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S1462399407000518

http://www.w3.org/2001/XMLSchema#string

P433

34

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5766624

http://www.w3.org/2001/XMLSchema#string

P698

18081947

http://www.w3.org/2001/XMLSchema#string

P921